Transport Characteristics of 6-Mercaptopurine in Brain Microvascular Endothelial Cells Derived From Human Induced Pluripotent Stem Cells.

Journal of Pharmaceutical Sciences
Toshiki KurosawaY Deguchi

Abstract

The likelihood of reoccurrence of acute lymphoblastic leukemia is influenced by the cerebral concentration of the therapeutic agent 6-mercaptopurine (6-MP) during treatment. Therefore, it is important to understand the blood-brain barrier (BBB) transport mechanism of 6-MP. The purpose of this study was to characterize this mechanism using human induced pluripotent stem cell-derived microvascular endothelial cells (hiPS-BMECs). The permeability coefficient of 6-MP across hiPS-BMECs monolayer in the basal-to-apical direction (B-to-A) was significantly greater than that in the opposite direction (A-to-B). The inhibition profiles of 6-MP transport in the A-to-B direction were different from those in the B-to-A direction. Transport in the A-to-B direction was mainly inhibited by adenine (an inhibitor of equilibrative nucleobase transporter 1; ENBT1), while transport in the B-to-A direction was significantly reduced by inhibitors of multidrug resistance-associated proteins (MRPs), especially zaprinast (an MRP5 inhibitor). Immunocytochemical analyses demonstrated the expression of ENBT1 and MRP5 proteins in hiPS-BMECs. We confirmed that the cellular uptake of 6-MP is decreased by ENBT1 inhibitors in hiPS-BMECs and by knockdown of ENBT...Continue Reading

References

Mar 1, 1968·Clinical Pharmacology and Therapeutics·T L LooE Frei
Jun 26, 2002·Biological & Pharmaceutical Bulletin·Kohji TakaraKatsuhiko Okumura
Apr 8, 2003·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Shinobu MoriTetsuya Terasaki
Apr 10, 2003·The Journal of Pharmacology and Experimental Therapeutics·Ryota KikuchiYuichi Sugiyama
Jul 3, 2003·Pflügers Archiv : European journal of physiology·Stephen A BaldwinJames D Young
Jul 12, 2003·Pflügers Archiv : European journal of physiology·Jennifer H GrayKathleen M Giacomini
Jan 23, 2004·Leukemia·M Pastor-AngladaJ Gil
Feb 5, 2011·Journal of Neurochemistry·Yasuo UchidaTetsuya Terasaki
Jun 26, 2012·Nature Biotechnology·Ethan S LippmannEric V Shusta
Mar 26, 2013·Lancet·Hiroto InabaCharles G Mullighan
Apr 29, 2015·Cell Biology and Toxicology·Mark M T J BroekmanDirk J de Jong
Mar 27, 2019·Molecular Pharmacology·Nicholas M RuelJames R Hammond
Nov 5, 2020·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Tatsuki MochizukiHiroyuki Kusuhara

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.